{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:28:32Z","timestamp":1782926912305,"version":"3.54.5"},"reference-count":229,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,4]],"date-time":"2018-11-04T00:00:00Z","timestamp":1541289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ncrna.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,4]],"date-time":"2018-11-04T14:39:20Z","timestamp":1541342360000},"page":"213-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma"],"prefix":"10.1016","volume":"3","author":[{"given":"Bernhard","family":"Biersack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncrna.2018.11.001_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/oemed-2017-104298","article-title":"Estimation of the global burden of mesothelioma deaths from incomplete national mortality data","volume":"74","author":"Odgerel","year":"2017","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.ncrna.2018.11.001_bib2","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1096\/fj.01-0150com","article-title":"5-Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor","volume":"15","author":"Romano","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.ncrna.2018.11.001_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fonc.2018.00091","article-title":"New perspectives on diagnosis and therapy of malignant pleural mesothelioma","volume":"8","author":"Rossini","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/2211536605666160128151018","article-title":"Prognostic and therapeutic implications of microRNA in malignant pleural mesothelioma","volume":"5","author":"Truini","year":"2016","journal-title":"MicroRNA"},{"key":"10.1016\/j.ncrna.2018.11.001_bib5","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00018-014-1584-5","article-title":"Role of microRNAs in malignant mesothelioma","volume":"71","author":"Truini","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ncrna.2018.11.001_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ncrna.2017.05.002","article-title":"Non-coding RNAs are promising targets for stem cell-based cancer therapy","volume":"2","author":"Sakamoto","year":"2017","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gdata.2016.06.009","article-title":"MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients","volume":"9","author":"Lin","year":"2016","journal-title":"Genomics Data"},{"key":"10.1016\/j.ncrna.2018.11.001_bib8","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib9","first-page":"42","article-title":"Roles, functions, and mechanisms of long non-coding RNAs in cancer","volume":"14","author":"Fang","year":"2016","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer: a long non-coding RNA point of view","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ncrna.2018.04.001","article-title":"Crosstalk mechanisms between the WNT signaling pathway and long non-coding RNAs","volume":"3","author":"Zarkou","year":"2018","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib12","first-page":"182","article-title":"Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma","volume":"3","author":"Zhang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ncrna.2018.11.001_bib13","first-page":"51","article-title":"New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials","volume":"7","author":"Kotova","year":"2015","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib14","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib15","first-page":"508","article-title":"Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future","volume":"1","author":"Nowak","year":"2012","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.ncrna.2018.11.001_bib16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomized, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ncrna.2018.11.001_bib17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/bjc.2013.368","article-title":"Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma","volume":"109","author":"Ceresoli","year":"2013","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ncrna.2018.08.001","article-title":"Relations between approved platinum drugs and non-coding RNAs in mesothelioma","author":"Biersack","year":"2018","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-199754030-00009","article-title":"Gemcitabine \u2013 a review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer","volume":"54","author":"Noble","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ncrna.2018.11.001_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/14737140.4.3.345","article-title":"Gemcitabine (Gemzar \u00ae) in non-small cell lung cancer","volume":"4","author":"Manegold","year":"2004","journal-title":"Expet Rev. Anticancer Ther."},{"key":"10.1016\/j.ncrna.2018.11.001_bib21","first-page":"6110","article-title":"Action of 2\u2019,2\u2019-difluorodeoxycytidine on DNA synthesis","volume":"51","author":"Huang","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1021\/mp300370t","article-title":"Gemcitabine versus modified gemcitabine: a review of several promising chemical modifications","volume":"10","author":"Moysan","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ncrna.2018.11.001_bib23","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.2004.10.142","article-title":"Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors","volume":"22","author":"Reid","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12885-015-1519-z","article-title":"The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma","volume":"15","author":"Ak","year":"2015","journal-title":"BMC Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib25","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jjco\/hyq101","article-title":"Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed","volume":"40","author":"Agatsuma","year":"2010","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib26","first-page":"1116","article-title":"LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes","volume":"57","author":"Shih","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/1535-7163.MCT-06-0343","article-title":"Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications","volume":"6","author":"Chattopadhyay","year":"2007","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ncrna.2018.11.001_bib28","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1158\/0008-5472.CAN-08-4979","article-title":"Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation and mammalian target of rapamycin inhibition","volume":"69","author":"Racanelli","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib29","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1200\/JCO.2009.25.9275","article-title":"Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy","volume":"28","author":"Righi","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib30","doi-asserted-by":"crossref","first-page":"16807","DOI":"10.18632\/oncotarget.24704","article-title":"Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer","volume":"9","author":"Tanino","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/00024669-200403060-00006","article-title":"Pemetrexed: a review of its use in malignant pleural mesothelioma and non-small cell lung cancer","volume":"3","author":"Robinson","year":"2004","journal-title":"Am. J. Cancer"},{"key":"10.1016\/j.ncrna.2018.11.001_bib32","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2165\/11202640-000000000-00000","article-title":"Pemetrexed \u2013 a review of its use in the management of advanced non-squameous non-small cell lung cancer","volume":"69","author":"Baldwin","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ncrna.2018.11.001_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/TCRM.S1603","article-title":"Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma","volume":"4","author":"Goudar","year":"2008","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.ncrna.2018.11.001_bib34","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1158\/1078-0432.982.11.3","article-title":"Pemetrexed in malignant pleural mesothelioma","volume":"11","author":"Hazarika","year":"2005","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.rmed.2009.07.019","article-title":"Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany","volume":"104","author":"Reck","year":"2010","journal-title":"Respir. Med."},{"key":"10.1016\/j.ncrna.2018.11.001_bib36","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2217\/fon-2017-0307","article-title":"A review of bevacizumab in the treatment of malignant pleural mesothelioma","volume":"13","author":"Brosseau","year":"2017","journal-title":"Future Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib37","doi-asserted-by":"crossref","first-page":"68627","DOI":"10.18632\/oncotarget.19800","article-title":"Downregulation of miR-99a\/let-7c\/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma","volume":"8","author":"Truini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib38","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.7150\/ijbs.13453","article-title":"Blockage of epithelial to mesenchymal transition and upregulation of let7b are critically involved in ursolic acid induced apoptosis in malignant mesothelioma cell","volume":"12","author":"Sohn","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ncrna.2018.11.001_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/635748","article-title":"MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion","volume":"2015","author":"Ak","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ncrna.2018.11.001_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2013.08.030","article-title":"MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3","volume":"342","author":"Zhao","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2018.11.001_bib41","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JTO.0b013e3182572e83","article-title":"Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma","volume":"7","author":"Kirschner","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib43","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib44","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3892\/or.2013.2351","article-title":"Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells","volume":"29","author":"Tanaka","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-016-0387-6","article-title":"Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET an AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism","volume":"10","author":"El Bizawy","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib46","doi-asserted-by":"crossref","first-page":"59604","DOI":"10.18632\/oncotarget.10730","article-title":"Large intergenic non-coding rna-ror reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib47","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3390\/ijms18102089","article-title":"MicroRNA-34a: a versatile regulator of myriads of targts in different cancers","volume":"18","author":"Farooqi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2018.11.001_bib48","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/aps.2015.153","article-title":"Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression","volume":"37","author":"Zhou","year":"2016","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ncrna.2018.11.001_bib50","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jmoldx.2014.03.002","article-title":"Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma","volume":"16","author":"Andersen","year":"2014","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.ncrna.2018.11.001_bib51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3892\/ol.2016.5388","article-title":"MiR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling","volume":"13","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ncrna.2018.11.001_bib52","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/onc.2013.476","article-title":"Protumorigenic effects of miR-145 loss in malignant pleural mesothelioma","volume":"33","author":"Cioce","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ncrna.2018.11.001_bib53","doi-asserted-by":"crossref","first-page":"70857","DOI":"10.18632\/oncotarget.12268","article-title":"MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells","volume":"7","author":"Lin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib54","doi-asserted-by":"crossref","first-page":"A222","DOI":"10.1093\/ajcp\/142.suppl1.222","article-title":"MiRNA 148a is highly expressed in malignant mesothelioma","volume":"142","author":"Esebua","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055513","article-title":"The rescue of miR-148a expression in pancreatic cancer: an appropriate therapeutic tool","volume":"8","author":"Delpu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib56","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/JTO.0b013e31820db125","article-title":"MicroRNAs dysregulated in human malignant pleural mesothelioma","volume":"6","author":"Balatti","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib57","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.18632\/oncotarget.2184","article-title":"MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis","volume":"5","author":"Xu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib58","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1007\/s10620-012-2400-4","article-title":"MiR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells","volume":"57","author":"Yan","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ncrna.2018.11.001_bib59","doi-asserted-by":"crossref","first-page":"17300","DOI":"10.18632\/oncotarget.24644","article-title":"MiR-21 overexpression and programmed cell death 4 down-regulation features malignant pleural mesothelioma","volume":"9","author":"Nicol\u00e8","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib60","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1007\/s13277-015-4604-7","article-title":"MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN\/AKT pathway in breast cancer","volume":"37","author":"Wu","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib61","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-09-4467","article-title":"MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity","volume":"70","author":"Giovannetti","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib62","first-page":"1473","article-title":"Chemosensitivity induced by down-regulation of microRNA-21 in gemcitabine-resistant pancreatic cancer cells by indole-3-carbinol","volume":"33","author":"Paik","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070940","article-title":"Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM)","volume":"8","author":"Wright","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-017-0587-x","article-title":"BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma","volume":"16","author":"Parasramka","year":"2017","journal-title":"Mol. Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ncrna.2018.08.002","article-title":"Long non-coding RNA and extracellular matrix: the hidden players in cancer-stroma cross-talk","author":"D'Angelo","year":"2018","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib66","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3390\/ijms19051297","article-title":"In silico and in vitro analyses of lncRNAs as potential regulators in the transition from the epitheloid to sarcomatoid histotype of malignant pleural mesothelioma (MPM)","volume":"19","author":"Singh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2018.11.001_bib67","first-page":"4773","article-title":"Gemcitabine treatment causes resistance and malignancy of pancreatic cancer stem-like cells via induction of lncRNA HOTAIR","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ncrna.2018.11.001_bib68","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.3390\/ijms16046677","article-title":"Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells","volume":"16","author":"Jiao","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2018.11.001_bib69","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/JTO.0000000000000202","article-title":"Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma","volume":"9","author":"Riquelme","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib70","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/carcin\/bgx065","article-title":"Curcumin sensitizes pancreatic cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression","volume":"38","author":"Yoshida","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2018.11.001_bib71","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jmoldx.2014.03.002","article-title":"Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma","volume":"16","author":"Andersen","year":"2014","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.ncrna.2018.11.001_bib72","doi-asserted-by":"crossref","first-page":"68627","DOI":"10.18632\/oncotarget.19800","article-title":"Downregulation of miR-99a\/let-7c\/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma","volume":"8","author":"Truini","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2013.08.030","article-title":"MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3","volume":"342","author":"Zhao","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2018.11.001_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/dvg.20623","article-title":"A new perspective on neural tube defects: folic acid and microRNA misexpression","volume":"48","author":"Shookhoff","year":"2010","journal-title":"Genesis"},{"key":"10.1016\/j.ncrna.2018.11.001_bib75","first-page":"937","article-title":"Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules","volume":"7","author":"Li","year":"2014","journal-title":"OncoTargets Ther."},{"issue":"3 Suppl","key":"10.1016\/j.ncrna.2018.11.001_bib76","article-title":"Abstract B37: investigating the potential of miR-203 as a therapeutic candidate and its role in the pathobiology of malignant pleural mesothelioma (MPM)","volume":"18","author":"Suraokar","year":"2012","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib77","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3892\/or.2017.5505","article-title":"Overexpression of miR-203 increases the sensitivity of NSCLC A549\/H460 cell lines to cisplatin by targeting Dickkopf-1","volume":"37","author":"Cheng","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib78","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3892\/or.2014.3481","article-title":"MiR-379\/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma","volume":"32","author":"Yamamoto","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib79","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/gcc.20880","article-title":"Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer","volume":"50","author":"Nymark","year":"2011","journal-title":"Genes Chromosomes Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib80","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41598-017-19004-3","article-title":"Gene and microRNA perturbations of cellular response to pemetrexed implicate biological networks and enable imputation of response in lung adenocarcinoma","volume":"8","author":"Gamazon","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib81","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.yexmp.2014.09.016","article-title":"Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets","volume":"97","author":"Ram\u00edrez-Salazar","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib82","doi-asserted-by":"crossref","first-page":"78193","DOI":"10.18632\/oncotarget.20409","article-title":"Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma","volume":"8","author":"Birnie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170999","article-title":"Identification of miR-21-5p as a functional regulator of mesothelin expression using microRNA capture affinity coupled with next generation sequencing","volume":"12","author":"De Santi","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib84","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","article-title":"MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","volume":"9","author":"Kirschner","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib85","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib86","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/03639045.2017.1391835","article-title":"Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells","volume":"44","author":"K\u00fcc\u00fckt\u00fcrkmen","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ncrna.2018.11.001_bib87","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.18632\/oncotarget.13708","article-title":"Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib88","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2147\/OTT.S157551","article-title":"Combination of long noncoding RNA MALAT I and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer","volume":"11","author":"Wei","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ncrna.2018.11.001_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jphs.2015.04.003","article-title":"EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells","volume":"128","author":"Hu","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ncrna.2018.11.001_bib90","first-page":"5239","article-title":"Scientific opinion on the safety of green tea catechins","volume":"16","author":"Younes","year":"2018","journal-title":"EFSA J"},{"key":"10.1016\/j.ncrna.2018.11.001_bib91","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1182\/blood-2009-03-204776","article-title":"Bortezomib and EGCG: no green tea for you?","volume":"113","author":"Shah","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ncrna.2018.11.001_bib92","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molcel.2010.03.007","article-title":"Genome-wide dissection of microRNA functions and cotargeting networks using genes et signatures","volume":"38","author":"Tsang","year":"2010","journal-title":"Mol. Cell."},{"issue":"Suppl. 11","key":"10.1016\/j.ncrna.2018.11.001_bib93","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2164-15-S11-S3","article-title":"Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer","volume":"15","author":"Zhou","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ncrna.2018.11.001_bib94","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1096\/fj.10-167924","article-title":"Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer","volume":"25","author":"Siddiqi","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.ncrna.2018.11.001_bib95","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/carcin\/bgr218","article-title":"Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1\u03b1","volume":"32","author":"Wang","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2018.11.001_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/srep19225","article-title":"Epigallocatechin-3-O-gallate up-regulates microRNA-let-7b expression by activating 67-kDa laminin receptor signaling in melanoma cells","volume":"6","author":"Yamada","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib97","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2407-13-421","article-title":"Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization","volume":"13","author":"Jang","year":"2013","journal-title":"BMC Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib98","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/1477-7819-12-383","article-title":"Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate","volume":"12","author":"Jiang","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib99","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3892\/or.2012.2083","article-title":"Involvement of microRNAs in epigallocatechin gallate-mediated UVB protection in human dermal fibroblasts","volume":"29","author":"An","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025982","article-title":"Proanthocyanidins modulate microRNA expression in human HepG2 cells","volume":"6","author":"Arola-Arnal","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib101","doi-asserted-by":"crossref","first-page":"43337","DOI":"10.18632\/oncotarget.9712","article-title":"NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/6662579f-3a41-4bce-9298-9d15f6582ef5","article-title":"Up-regulation of microRNA-21 correlates with lower kidney cancer survival","volume":"7","author":"Zaman","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib103","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3892\/ol.2011.460","article-title":"Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer","volume":"3","author":"Rhodes","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ncrna.2018.11.001_bib104","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/bcr3194","article-title":"MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis","volume":"14","author":"Chang","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/1940-6207.CAPR-14-0357","article-title":"3,6-Dihydroxyflavone suppresses breast carcinogenesis by epigenetically regulating miR-34a and miR-21","volume":"8","author":"Chang","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib106","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/srep02459","article-title":"Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21\/low miR-200c signature in vivo","volume":"3","author":"Cufi","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib107","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/mc.22333","article-title":"Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: an epigenetic regulation of miR-148a\/SMAd2 signaling","volume":"55","author":"Jiang","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ncrna.2018.11.001_bib108","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1159\/000374024","article-title":"The p53\/miR-34a\/SIRT1 positive feedback loop in quercetin-induced apoptosis","volume":"35","author":"Lou","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ncrna.2018.11.001_bib109","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.3390\/nu7064578","article-title":"Quercetin decreases claudin-2 expression mediated by upregulation of microRNA miR-16 in lung adenocarcinoma","volume":"7","author":"Sonoki","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.ncrna.2018.11.001_bib110","article-title":"The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells","volume":"9","author":"Jiang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070372","article-title":"Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR","volume":"8","author":"Chiyomaru","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib112","first-page":"722","article-title":"Calycosin and genistein induce apoptosis by inactivation of HOTAIR\/p-Akt signaling pathway in human breast cancer MCF-7 cells, Cell","volume":"35","author":"Chen","year":"2015","journal-title":"Physiol. Biochem."},{"key":"10.1016\/j.ncrna.2018.11.001_bib113","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-9966-31-27","article-title":"Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells","volume":"31","author":"Gao","year":"2012","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030590","article-title":"Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling","volume":"7","author":"Subramaniam","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib115","first-page":"403","article-title":"Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells","volume":"9","author":"Mirgani","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ncrna.2018.11.001_bib116","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1158\/1940-6207.CAPR-11-0267","article-title":"Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer","volume":"4","author":"Saini","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib117","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/1471-2407-12-564","article-title":"Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (sp) transcription factors by targeting microRNAs","volume":"12","author":"Gandhy","year":"2012","journal-title":"BMC Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib118","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/BSR20100065","article-title":"Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cells","volume":"31","author":"Mudduluru","year":"2011","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib119","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12094-013-1135-9","article-title":"MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells","volume":"16","author":"Zhang","year":"2014","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib120","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.7314\/APJCP.2014.15.10.4239","article-title":"Influence of curcumin on HOTAIR-mediated migration of human renal cell carcinoma cells","volume":"15","author":"Pei","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.ncrna.2018.11.001_bib121","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcb.21742","article-title":"Curcumin downregulates H19 gene transcription in tumor cells","volume":"104","author":"Kujundzic","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ncrna.2018.11.001_bib122","article-title":"Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF","volume":"7","author":"Bao","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib123","article-title":"Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment","volume":"7","author":"Bao","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib124","article-title":"The curcumin analog EF24 targets NF-\u03baB and miRNA-21, and has potent anticancer activity in vitro and in vivo","volume":"8","author":"Yang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2014.05.013","article-title":"Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling","volume":"351","author":"Ali","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2018.11.001_bib126","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.bcp.2010.07.003","article-title":"Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGF-beta signaling pathway in SW480 cells","volume":"80","author":"Tili","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib127","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12094-012-0999-4","article-title":"Resveratrol induces apoptosis of pancreatic cancer cells by inhibiting miR-21 regulation of Bcl-2 expression","volume":"15","author":"Liu","year":"2013","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib128","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jnutbio.2013.04.006","article-title":"Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells","volume":"24","author":"Kumazaki","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ncrna.2018.11.001_bib129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1186\/s12885-015-1958-6","article-title":"Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo","volume":"15","author":"Yang","year":"2015","journal-title":"BMC Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/srep00314","article-title":"Stilbene derivatives promote AGO2-dependent tumour-suppressive micro-RNA activity","volume":"2","author":"Hagiwara","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib131","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-015-1718-0","article-title":"Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells","volume":"122","author":"Liu","year":"2015","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib132","article-title":"Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt\/\u03b2-catenin signal pathway","volume":"11","author":"Li","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib133","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.18632\/oncotarget.3844","article-title":"Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-\u03b2-catenin signaling axis in a microRNA-34a dependent manner","volume":"6","author":"Avtanski","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib134","doi-asserted-by":"crossref","first-page":"37335","DOI":"10.18632\/oncotarget.6135","article-title":"Honokiol inhibits bladder tumor growth by suppressing EZH2\/miR-143 axis","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2018.11.001_bib135","doi-asserted-by":"crossref","DOI":"10.1038\/srep14697","article-title":"A robust screening method for dietary agents that activate tumour-suppressor microRNAs","volume":"5","author":"Hagiwara","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib136","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11010-013-1726-3","article-title":"Emodin can induce K562 cells to erythroid differentiation and improve expression of globin genes","volume":"382","author":"Ma","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ncrna.2018.11.001_bib137","first-page":"2085","article-title":"miR-211 and miR-429 are involved in emodin's anti-proliferative effects on lung cancer","volume":"9","author":"Ren","year":"2016","journal-title":"Int. J. Clin. Med."},{"key":"10.1016\/j.ncrna.2018.11.001_bib138","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.3892\/mmr.2015.4158","article-title":"Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-\u03b2\/drosophila mothers against decapentaplegic pathway and angiogenesis-associated micro-RNAs","volume":"12","author":"Lin","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib139","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1038\/emm.2015.36","article-title":"Emodin prevents intima sickness via Wnt4\/Dvl-1\/\u03b2-catenin signaling pathway mediated by miR-126 in balloon-injured carotid artery rats","volume":"47","author":"Hua","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ncrna.2018.11.001_bib140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mnfr.201200297","article-title":"Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures","volume":"57","author":"Parasramka","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib141","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1158\/1535-7163.MCT-12-0232-T","article-title":"Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer","volume":"11","author":"Ahmad","year":"2012","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ncrna.2018.11.001_bib142","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.fob.2015.05.009","article-title":"Blockade of TGF\u03b2-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo","volume":"5","author":"Li","year":"2015","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ncrna.2018.11.001_bib143","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.3892\/or.2015.3919","article-title":"Mangiferin regulates proliferation and apoptosis in glioma cells by induction of microRNA-15b and inhibition of MMP-9 expression","volume":"33","author":"Xiao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib144","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ptr.5267","article-title":"Antiproliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53\/miR-34a axis","volume":"29","author":"Zhou","year":"2015","journal-title":"Phytother Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2165\/00003495-199039030-00008","article-title":"Etoposide. A review of its pharmacodynamics and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer","volume":"39","author":"Henwood","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.ncrna.2018.11.001_bib146","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","article-title":"Etoposide: four decades of development of a topoisomerase II inhibitor","volume":"34","author":"Hande","year":"1998","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114757","article-title":"p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression","volume":"9","author":"Novello","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib148","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1517\/13543784.2012.727395","article-title":"Terpenoids: natural products for cancer therapy","volume":"21","author":"Huang","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ncrna.2018.11.001_bib149","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3892\/mmr.2015.3718","article-title":"Paeoniflorin inhibits proliferation and induces apoptosis of human glioma cells via microRNA-16 upregulation and matrix metalloproteinaase-9 downregulation","volume":"12","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biomaterials.2015.01.007","article-title":"PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a","volume":"51","author":"Bhattacharya","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ncrna.2018.11.001_bib151","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/carcin\/bgt255","article-title":"A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2\/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells","volume":"34","author":"Yeh","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2018.11.001_bib152","doi-asserted-by":"crossref","first-page":"44095","DOI":"10.1074\/jbc.M111.265439","article-title":"Nucleolin protein interacts with microprocessor complex to affect biogenesis of microRNAs 15a and 16","volume":"286","author":"Pickering","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ncrna.2018.11.001_bib153","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-0500-3-24","article-title":"Non-coding RNAs change their expression profile after retinoid induced differentiation of the pro-myelocytic cell line NB4","volume":"3","author":"Rossi","year":"2010","journal-title":"BMC Res"},{"key":"10.1016\/j.ncrna.2018.11.001_bib154","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1038\/sj.onc.1210186","article-title":"MicroRNA gene expression during retinoid acid-induced differentiation of human acute promyelocytic leukemia","volume":"26","author":"Garzon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ncrna.2018.11.001_bib155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2840-13-8","article-title":"Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to diabetic-like environment","volume":"13","author":"Zitman-Gal","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib156","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1002\/ijc.27549","article-title":"Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in non-small cell lung cancer cells","volume":"131","author":"Ji","year":"2012","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib157","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mrfmmm.2010.12.009","article-title":"Antroquinonol inhibits NSCLC proliferation by altering PI3K\/mTOR proteins and miRNA expression profiles","volume":"707","author":"Kumar","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib158","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1742-7843.2012.00870.x","article-title":"Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-\u03b21\/miR-21\/PDCD4 pathway","volume":"111","author":"Wang","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib159","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/jid.2010.349","article-title":"MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in S\u00e9zary syndrome","volume":"131","author":"van der Fits","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/aps.2010.220","article-title":"Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128","volume":"32","author":"Wu","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ncrna.2018.11.001_bib161","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/or.2012.2136","article-title":"Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells","volume":"29","author":"An","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib162","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1940-6207.CAPR-14-0354","article-title":"Novel evidence for curcumin and boswellic acid-induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer","volume":"8","author":"Toden","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib163","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/carcin\/bgs286","article-title":"Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family","volume":"33","author":"Takahashi","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2018.11.001_bib164","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2165\/00003495-199448050-00009","article-title":"Paclitaxel. A review of its pharmacodynamics and pharmacokinetic properties and therapeutic potential in the treatment of cancer","volume":"48","author":"Spencer","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.ncrna.2018.11.001_bib165","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/bjc.1996.465","article-title":"Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC lung cancer cooperative group","volume":"74","author":"van Meerbeeck","year":"1996","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib166","first-page":"1001","article-title":"A case of malignant peritoneal mesothelioma successfully treated with carboplatin and paclitaxel","volume":"33","author":"Ogura","year":"2007","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.ncrna.2018.11.001_bib167","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/rcr2.145","article-title":"Repetitive responses to nanoparticle albumin-bound paclitaxel and carboplatin in malignant pleural mesothelioma","volume":"4","author":"Kanai","year":"2016","journal-title":"Respirol. Case Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib168","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jcp.24730","article-title":"Neoadjuvant chemotherapy in breast cancer patients induces miR-34a and miR-122 expression","volume":"230","author":"Fr\u00e8res","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib169","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000334237","article-title":"MiR-34a expression, cell cycle arrest and cell death of malignant mesothelioma cells upon treatment with radiation, docetaxel or combination treatment","volume":"81","author":"Ghawanmeh","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.ncrna.2018.11.001_bib170","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1158\/1078-0432.CCR-04-0163","article-title":"Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice","volume":"10","author":"Anderton","year":"2004","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib171","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/carcin\/bgp208","article-title":"Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol","volume":"31","author":"Melkamu","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2018.11.001_bib172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033729","article-title":"Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM","volume":"7","author":"Kong","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib173","first-page":"432","article-title":"Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness","volume":"4","author":"Kashat","year":"2012","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib174","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054657","article-title":"3,3\u2019-Diindolylmethane enhances the effectiveness of herceptin against HER-2\/neu-expressing breast cancer cells","volume":"8","author":"Ahmad","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib175","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Upregulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib176","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ncrna.2016.09.001","article-title":"Non-coding RNA\/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins","volume":"1","author":"Biersack","year":"2016","journal-title":"Non-coding RNA Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib177","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1517\/13543784.13.3.269","article-title":"Camptothecins in clinical development","volume":"13","author":"Zunino","year":"2004","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ncrna.2018.11.001_bib178","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ygyno.2009.01.014","article-title":"MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy","volume":"113","author":"Boren","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib179","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1039\/C4NP00051J","article-title":"Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics","volume":"32","author":"Le","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib180","doi-asserted-by":"crossref","first-page":"8513","DOI":"10.1200\/JCO.2017.35.15_suppl.8513","article-title":"Trabectedin (T) as a second line treatment option for patients with epithelioid malignant pleural mesothelioma (MPM) in progression following pemetrexed\/platin-derivates chemotherapy: ATREUS trial","volume":"35","author":"Cortinovis","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib181","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1200\/jco.2015.33.15_suppl.7561","article-title":"Activity and safety of trabectedin in patients with sarcomatoid\/biphasic malignant pleural mesothelioma (MPM)","volume":"33","author":"Cortinovis","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib182","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035423","article-title":"A systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcoma","volume":"7","author":"Uboldi","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib183","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/abbs\/gmt075","article-title":"Berberine sensitizes ovarian cancer cells to cisplatin through miR-21\/PDCD4 axis","volume":"45","author":"Liu","year":"2013","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ncrna.2018.11.001_bib184","doi-asserted-by":"crossref","DOI":"10.1038\/srep14697","article-title":"A robust screening method for dietary agents that activate tumour-suppressor microRNAs","volume":"5","author":"Hagiwara","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00227","article-title":"Epigenetic impacts of ascorbate on human metastatic melanoma cells","volume":"4","author":"Venturelli","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib186","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/j.1753-4887.2008.00064.x","article-title":"Differential expression of microRNAs during hepatocarcinogenesis induced by methyl deficiency in rats","volume":"66","author":"Pogribny","year":"2008","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ncrna.2018.11.001_bib187","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/carcin\/bgp245","article-title":"n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon","volume":"30","author":"Davidson","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2018.11.001_bib188","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/carcin\/bgs198","article-title":"MiR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression","volume":"33","author":"Mandal","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ncrna.2018.11.001_bib189","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1476-511X-10-173","article-title":"MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes","volume":"10","author":"Farag\u00f3","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ncrna.2018.11.001_bib190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/1940-6207.CAPR-09-0202","article-title":"Chemoprevention of cigarette smoke-induced alterations of microRNA expression in rat lungs","volume":"3","author":"Izzotti","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib191","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112720","article-title":"Diallyl sulfide suppresses SRC\/Ras\/ERK signaling-mediated proliferation and metastasis in human breast cancer by up-regulating miR-34a","volume":"9","author":"Xiao","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib192","doi-asserted-by":"crossref","unstructured":"G. Wang, G. Liu, Y. Ye, Y. Fu, X. Zhang, Upregulation of miR-34a by diallyl disulfide suppresses invasion and induces apoptosis in SCG-7901 cells through inhibition of the PI3K\/Akt signaling pathway, Oncol. Lett. 11 (016) 2661-2667.","DOI":"10.3892\/ol.2016.4266"},{"key":"10.1016\/j.ncrna.2018.11.001_bib193","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/01635581.2013.756530","article-title":"Identification of microRNAs regulated by isothiocyanates and association of polymorphisms inside their target sites with risk of sporadic colorectal cancer","volume":"65","author":"Slaby","year":"2013","journal-title":"Nutr. Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib194","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2013.06.027","article-title":"Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22","volume":"340","author":"Tang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2018.11.001_bib195","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jnutbio.2012.08.004","article-title":"Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2\/MMP2\/Snail, ZEB1 and miR-200c\/ZEB1 pathways in human bladder cancer cells","volume":"24","author":"Shan","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ncrna.2018.11.001_bib196","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/14789450.2.5.719","article-title":"Histone structure and nucleosome stability","volume":"2","author":"Marino-Ram\u00edrez","year":"2005","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.ncrna.2018.11.001_bib197","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ncrna.2018.11.001_bib198","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2018.11.001_bib199","first-page":"983","article-title":"Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K\/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101","volume":"93","author":"Ferreira","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib200","article-title":"The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer","volume":"6","author":"Hu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ncrna.2018.11.001_bib201","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-013-1762-z","article-title":"Histone deacetylase inhibitor trichostatin A increases the expression of Dleu2\/miR-15a\/16-1 via HDAC3 in non-small cell lung cancer","volume":"383","author":"Chen","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ncrna.2018.11.001_bib202","first-page":"983","article-title":"Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K\/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101","volume":"93","author":"Ferreira","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib203","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","article-title":"Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells","volume":"9","author":"Saito","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ncrna.2018.11.001_bib204","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/mt.2014.247","article-title":"HDAC inhibitors target HDAC5, upregulate microRNA-125a-5p, and induce apoptosis in breast cancer cells","volume":"23","author":"Hsieh","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ncrna.2018.11.001_bib205","first-page":"10","article-title":"The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells","volume":"27","author":"Rhodes","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ncrna.2018.11.001_bib206","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/ijc.25162","article-title":"MiR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer","volume":"127","author":"Rauhala","year":"2010","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib207","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.canlet.2014.07.019","article-title":"Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes","volume":"353","author":"Seol","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2018.11.001_bib208","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood-2011-05-351510","article-title":"Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia","volume":"119","author":"Sampath","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ncrna.2018.11.001_bib209","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/onc.2011.470","article-title":"Myc represses miR-15a\/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ncrna.2018.11.001_bib210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2013.05.061","article-title":"Epigenetic regulation of microRNA expression in renal cell carcinoma","volume":"436","author":"Schiffgen","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ncrna.2018.11.001_bib211","article-title":"MiR-449 and HDAC modulates HOTAIR expression which predicts poor prognosis in resected gastro-esophageal adenocarcinomas and doubles proliferation rate in HFE145 cells","volume":"3","author":"Stickertson","year":"2017","journal-title":"J. Gastric Discord. Ther."},{"key":"10.1016\/j.ncrna.2018.11.001_bib212","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1158\/0008-5472.CAN-10-2259","article-title":"Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels","volume":"71","author":"Kretzner","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib213","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4161\/cbt.20086","article-title":"A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells","volume":"13","author":"Balch","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ncrna.2018.11.001_bib214","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/0008-5472.CAN-05-3632","article-title":"Rapid alteration of microRNA levels by histone deacetylase inhibition","volume":"66","author":"Scott","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib215","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.yexcr.2012.04.018","article-title":"Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on has-let-7b expression in liver cancer cell lines","volume":"318","author":"Di Fazio","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib216","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.febslet.2011.06.025","article-title":"Epigenetic regulation of microRNA-375 and its role in melanoma development in humans","volume":"585","author":"Mazar","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ncrna.2018.11.001_bib217","first-page":"45","article-title":"Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells","volume":"24","author":"Lee","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ncrna.2018.11.001_bib218","doi-asserted-by":"crossref","first-page":"10555","DOI":"10.1074\/jbc.M114.624361","article-title":"MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cell senescence","volume":"290","author":"Cho","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ncrna.2018.11.001_bib219","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ddr.21268","article-title":"Impact of histone deacetylase inhibitors on microRNA expression and cancer therapy: a review","volume":"76","author":"Ali","year":"2015","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ncrna.2018.11.001_bib220","series-title":"Breast Cancer Metastasis and Drug Resistance","first-page":"227","article-title":"Resistance to anthracyclines and taxanes in breast cancer","author":"Edwardson","year":"2013"},{"key":"10.1016\/j.ncrna.2018.11.001_bib221","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1158\/1535-7163.MCT-08-0021","article-title":"Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin","volume":"7","author":"Kovalchuk","year":"2008","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ncrna.2018.11.001_bib222","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12032-014-0458-x","article-title":"Third-line chemotherapy with carboplatin, gemcitabine and liposomised doxorubicin for malignant pleural mesothelioma","volume":"32","author":"de Lima","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib223","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/cncr.22366","article-title":"Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma","volume":"109","author":"Fennell","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ncrna.2018.11.001_bib224","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/stem.741","article-title":"MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells","volume":"29","author":"Bitarte","year":"2011","journal-title":"Stem Cell."},{"key":"10.1016\/j.ncrna.2018.11.001_bib225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.lungcan.2008.04.001","article-title":"The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma","volume":"63","author":"Stebbing","year":"2009","journal-title":"Lung Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib226","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lungcan.2013.11.011","article-title":"Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma","volume":"84","author":"Zucali","year":"2014","journal-title":"Lung Canc."},{"key":"10.1016\/j.ncrna.2018.11.001_bib227","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gene.2014.11.046","article-title":"MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells","volume":"556","author":"Zhong","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.ncrna.2018.11.001_bib228","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/JTO.0b013e31828c2b26","article-title":"Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy","volume":"8","author":"Papa","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ncrna.2018.11.001_bib229","doi-asserted-by":"crossref","first-page":"73257","DOI":"10.18632\/oncotarget.12304","article-title":"An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"}],"updated-by":[{"DOI":"10.1016\/j.ncrna.2020.11.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054018300921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054018300921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:38:43Z","timestamp":1720748323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054018300921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":229,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2468054018300921"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2018.11.001","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ncrna.2020.11.001","asserted-by":"object"}]},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}